ClinicalTrials.govpublic full text
A Trial That Compare Two Treatments in Newly Diagnosed Myeloma Patients Not Eligible for Transplant
multiple myeloma, new diagnosis tumor, autologous stem cell transplantation ineligible, proteasome inhibitor, immunomodulating agents, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 904981
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.